Back to top
more

Akorn, Inc. (AKRX)

(Delayed Data from NSDQ)

$2.85 USD

2.85
1,371,052

+0.14 (5.17%)

Updated May 3, 2019 04:00 PM ET

After-Market: $2.86 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Akorn (AKRX) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Akorn's (AKRX) fourth-quarter 2019 results are likely to reflect a decline in sales volume due to stiffening competition.

Akorn Enters Oversold Territory

by Zacks Equity Research

Akorn, Inc. (AKRX) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

Akorn (AKRX) Moves to Strong Buy: Rationale Behind the Upgrade

by Zacks Equity Research

Akorn (AKRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Indrajit Bandyopadhyay headshot

Generic Drugmakers Gain as Price-Fixing Probe Nears an End

by Indrajit Bandyopadhyay

Shares of generic drugmakers rose on Monday on a possible end to the persistent price-fixing probe.

Indrajit Bandyopadhyay headshot

Generic Drugs Industry Turns the Corner on Price Stabilization

by Indrajit Bandyopadhyay

Stabilizing prices of generic drugs are leading to recovery in the industry. New launches are also a boost. However, competition remains stiff.

The Zacks Analyst Blog Highlights: Forterra, Barrett Business, Chuy's, Akorn and Quanex

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Forterra, Barrett Business, Chuy's, Akorn and Quanex.

Nalak Das headshot

5 Small-Cap Stocks Outpacing the Broader Market in 2019

by Nalak Das

Despite the slow pace of movement of small-cap stock prices, a few stocks within this stable have skyrocketed ahead of the large-cap-centric indexes this year.

Nitish Marwah headshot

New Strong Buy Stocks for November 7th

by Nitish Marwah

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday

Akorn (AKRX) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

Akorn (AKRX) delivered earnings and revenue surprises of 150.00% and 0.67%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Will Akorn (AKRX) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

Akorn (AKRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

All You Need to Know About Akorn (AKRX) Rating Upgrade to Buy

by Zacks Equity Research

Akorn (AKRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Akorn (AKRX) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Akorn (AKRX) delivered earnings and revenue surprises of 66.67% and 3.27%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Akorn (AKRX) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Akorn (AKRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Akorn (AKRX) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Akorn (AKRX) delivered earnings and revenue surprises of 28.57% and 8.44%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Options Traders Expect Huge Moves in Akorn (AKRX) Stock

by Zacks Equity Research

Investors need to pay close attention to Akorn (AKRX) stock based on the movements in the options market lately.

Options Traders Expect Huge Moves in Akorn (AKRX) Stock

by Zacks Equity Research

Investors need to pay close attention to Akorn (AKRX) stock based on the movements in the options market lately.

Akorn (AKRX) Gets FDA Warning Letter for Illinois Facility

by Zacks Equity Research

Akorn, Inc. (AKRX) suffers a setback with the FDA handing over a warning letter post an inspection of its Illinois manufacturing facility in April and May of 2018.

Do Options Traders Know Something About Akorn (AKRX) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to Akorn (AKRX) stock based on the movements in the options market lately.

Is Akorn (AKRX) Stock a Suitable Pick for Value Investors?

by Zacks Equity Research

Let's see if Akorn, Inc. (AKRX) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

Implied Volatility Surging for Akorn (AKRX) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Akorn (AKRX) stock based on the movements in the options market lately.

Is Akorn (AKRX) a Suitable Stock for Value Investors Now?

by Zacks Equity Research

Let's see if Akorn, Inc. (AKRX) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

    AKRX vs. AMPH: Which Stock Should Value Investors Buy Now?

    by Zacks Equity Research

    AKRX vs. AMPH: Which Stock Is the Better Value Option?

      Bausch (BHC) Looks Good: Stock Adds 13.9% in Session

      by Zacks Equity Research

      Bausch (BHC) shares rose nearly 14% in the last trading session, amid huge volumes.

        Akorn Enters Oversold Territory

        by Zacks Equity Research

        Akorn has been on a bit of a cold streak lately.

          AKRX vs. AMPH: Which Stock Should Value Investors Buy Now?

          by Zacks Equity Research

          AKRX vs. AMPH: Which Stock Is the Better Value Option?